ARQT 8-K 2026-11-04

Arcutis Biotherapeutics, Inc. (ARQT) 8-K dated 2026-11-04 — accession 0001787306-26-000056.

Arcutis Biotherapeutics, Inc. (ARQT) is a biotechnology company listed on US.

Arcutis Biotherapeutics, Inc. filed a 8-K on 2026-11-04. Accession 0001787306-26-000056.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ARQT revenue for 2025-12-31 was $376.1M. Net income was -$16.1M. Revenue was up 91.3% from 2024-12-31 to 2025-12-31. ARQT currently screens at market cap $1.64B.

Not investment advice. The ARQT SEC hub lists recent forms. The stock page is the research view.